Dosing & Administration for mRESVIA® (Respiratory Syncytial Virus Vaccine)

The only adult RSV protection available in a pre-filled syringe^1-3
Ready to protect against RSV. No reconstitution required.¹ mRESVIA is a single-dose 0.5 mL pre-filled syringe, ready for you to use for protection against RSV.¹
Pre-filled syringes offer a convenient way to administer protection.^1,4,5

Pre-filled syringe (PFS) and mRESVIA Respiratory Syncytial Virus Vaccine box

mRESVIA Box Dimensions: 55 x 87 x 133mm

Storage and handling options¹

Your mRESVIA pre-filled syringes can be stored in a freezer, refrigerator, or at room temperature, with varying storage times.¹*

Store in the freezer

-40°F to 5°F (-40°C to -15°C)¹

Store up to 90 days^† in the refrigerator

36°F to 46°F (2°C to 8°C)¹

Thaw duration in refrigerator 100 minutes (Individual pre-filled syringe)¹ or 160 minutes (carton of 10)¹

Store up to 24 hours^‡ at room temperature

46°F to 77°F (8°C to 25°C)¹

Thaw duration at 59°F to 77°F (15°C to 25°C) 40 minutes (Individual pre-filled syringe)¹ or 80 minutes (carton of 10)¹

Storage and administration considerations

Do not shake mRESVIA¹
Avoid exposure to direct sunlight and/or ultraviolet light, and minimize exposure to room light¹
Do not refreeze after thawing or refrigerate after storing at room temperature¹

Check out the mRESVIA Product Information Quick Guide

Download now

*If thawed in the refrigerator, syringes should be left at room temperature for an additional 10 to 20 minutes before administration. Discard any syringes left at room temperature for over 24 hours.¹

^†Following frozen storage.¹

^‡Following refrigerated storage.¹

RSV = respiratory syncytial virus.

Indication and Important Safety Information

Indication

mRESVIA® (Respiratory Syncytial Virus Vaccine) is a vaccine indicated for active immunization for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in adults 60 years of age and older.

Important Safety Information

Contraindications

Do not administer mRESVIA to individuals with a history of severe allergic reaction (e.g., anaphylaxis) to any component of mRESVIA.

Warnings and Precautions

Management of Acute Allergic Reactions: Appropriate medical treatment must be immediately available to manage potential anaphylactic reactions following administration of mRESVIA.
Syncope: Syncope (fainting) may occur in association with administration of injectable vaccines, including mRESVIA. Procedures should be in place to avoid injury from fainting.
Altered Immunocompetence: Immunocompromised individuals, including those receiving immunosuppressive therapy, may have a diminished immune response to mRESVIA.

Adverse Reactions

In a clinical trial, the most commonly reported (≥10%) adverse reactions were injection-site pain (55.9%), fatigue (30.8%), headache (26.7%), myalgia (25.6%), arthralgia (21.7%), axillary (underarm) swelling or tenderness (15.2%) and chills (11.6%).

To report suspected adverse reactions, contact ModernaTX, Inc. at 1-866-663-3762 or VAERS at 1-800-822-7967 or www.vaers.hhs.gov.

Please click for mRESVIA Full Prescribing Information.

References

mRESVIA Prescribing Information. ModernaTX, Inc.
AREXVY Prescribing Information. GlaxoSmithKline Biologics SA.
ABRYSVO Product Information. Pfizer Inc.
Icardi G, Orsi A, Vitali Rosati G, Tognetto A, Checcucci Lisi G, Parisi S. Preferences of healthcare professionals regarding hexavalent pediatric vaccines in Italy: a survey of attitudes and expectations. J Prev Med Hyg. 2020;61(3):E424-E444. doi:10.15167/2421-4248/jpmh2020.61.3.1535
Yarnoff B, Bodhaine S, Cohen E, Buck PO. Time and cost of administering COVID-19 mRNA vaccines in the United States. Hum Vaccin Immunother. 2021;17(11):3871-3875. doi:10.1080/21645515.2021.1974289

For Colorado and Connecticut price disclosure, please visit https://modernadirect.com/wac-disclosure

Stay up to date

Receive the latest information about mRESVIA and all the products in the Moderna pipeline.

By submitting your information, you agree to Moderna's Terms and Conditions. You also acknowledge that your information will be processed in accordance with Moderna's Privacy Statement. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.